Pharmaceutical Technology on MSN1d
Servier and Black Diamond sign deal for solid tumours therapyServier will be responsible for development and global commercialisation of the therapy for several indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback